FBT
ยทNYSE
--
--(--)
--
--(--)
Key Stats
Assets Under Management
1.37BUSD
Fund Flows (1Y)
-35.86MUSD
Dividend Yield
0.55%
Discount/Premium to NAV
0.19%
Shares Outstanding
6.50M
Expense Ratio
0.54%
About First Trust NYSE Arca Biotechnology Index Fund
Issuer
First Trust Advisors L.P.
Brand
First Trust
Inception Date
Jun 19, 2006
Structure
Open-Ended Fund
Index Tracked
NYSE Arca Biotechnology Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
First Trust Advisors LP
Distributor
First Trust Portfolios LP
FBT provides exposure to biotech companies involved in the use of biological processes to develop products or provide services. The underlying index contains 30 names, an increase from 20 in October 2014. Without a specific sector classification scheme, the fund's broad exposure could include access to pharmaceuticals and medical technology in addition to traditional biotech. Still, FBT's equal weighting of about 30 stocks produces a relatively concentrated basket. The index is reconstituted and rebalanced quarterly.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Biotechnology
Strategy
Equal
Geography
U.S.
Weighting Scheme
Equal
Selection Criteria
Market cap
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | +3.54% | +20.00% | +28.54% | +30.32% | +37.98% | +23.37% |
NAV Total Return | +5.55% | +17.98% | +27.59% | +28.66% | +38.65% | +24.90% |
Ratings
No data is currently available
Ainvestโs AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investorsโtransforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region

97.12%
2.88%
Category
Ratio
North America
97.12%
Europe
2.88%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Growth
Comprises companies of multiple sizes that have high growth potential. These ETFs focus on firms across different market caps with promising growth prospects.
Top 10 Holdings
Symbol
Ratio
EXAS
Exact Sciences
4.99%
ILMN
Illumina
4.11%
NTRA
Natera
3.92%
REGN
Regeneron
3.89%
ACAD
Acadia Pharmaceuticals
3.87%
KRYS
Krystal Biotech
3.79%
BRKR
Bruker
3.77%
MRNA
Moderna
3.60%
VCYT
Veracyte
3.53%
INCY
Incyte
3.50%
Top 10 Weight 38.97%
31 Total Holdings
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2024-12-13 | 2024-12-13 | 2024-12-31 | 1.173 |
| 2021-12-30 | 2021-12-31 | 2022-01-10 | 2.214 |
Premium/Discount Chart
Premium/Discount to NAV
Price
1M
Assets Under Management
Assets Under Management
1M
Fund Flows
Inflows
Outflows
1M
